I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Durvalumab with olaparib and paclitaxel for high-risk HER2-..:
Pusztai, Lajos
;
Yau, Christina
;
Han, Hyo
...
qt3r25p13v. , 2021
Link:
https://escholarship.org/uc/item/3r25p13v
RT Journal T1
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt3r25p13v&Exemplar=1&LAN=DE A1 Pusztai, Lajos A1 Yau, Christina A1 Han, Hyo A1 Du, Lili A1 Wallace, Anne A1 String-Reasor, Erica A1 Boughey, Judy A1 Chien, A A1 Elias, Anthony A1 Beckwith, Heather A1 Nanda, Rita A1 Albain, Kathy A1 Clark, Amy A1 Kemmer, Kathleen A1 Kalinsky, Kevin A1 Isaacs, Claudine A1 Thomas, Alexandra A1 Helsten, Theresa A1 Forero-Torres, Andres A1 Liu, Minetta A1 Brown-Swigart, Lamorna A1 Petricoin, Emmanuel A1 Wulfkuhle, Julia A1 Asare, Smita A1 Wilson, Amy A1 Singhrao, Ruby A1 Sit, Laura A1 Berry, Scott A1 Sanil, Ashish A1 Asare, Adam A1 Matthews, Jeffrey A1 Perlmutter, Jane A1 Melisko, Michelle A1 Rugo, Hope A1 Schwab, Richard A1 Symmans, W A1 Yee, Doug A1 Vant Veer, Laura A1 DeMichele, Angela A1 Berry, Donald A1 Esserman, Laura A1 Hylton, Nola A1 Wolf, Denise A1 Shatsky, Rebecca A1 Hirst, Gillian PB eScholarship, University of California YR 2021 K1 DNA repair inhibitor K1 breast cancer K1 clinical trial K1 immunotherapy K1 Adult K1 Aged K1 80 and over K1 Antibodies K1 Monoclonal K1 Antineoplastic Combined Chemotherapy Protocols K1 Breast Neoplasms K1 Female K1 Follow-Up Studies K1 Humans K1 Middle Aged K1 Neoadjuvant Therapy K1 Paclitaxel K1 Phthalazines K1 Piperazines K1 Prognosis K1 Receptor K1 ErbB-2 K1 Survival Rate K1 Young Adult JF qt3r25p13v LK http://dx.doi.org/https://escholarship.org/uc/item/3r25p13v DO https://escholarship.org/uc/item/3r25p13v SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)